البلد: أستراليا
اللغة: الإنجليزية
المصدر: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CICLESONIDE
Boehringer Ingelheim Animal Health Australia Pty. Ltd.
Inhalation solution
CICLESONIDE Active 30.0 mg/ml
4.3 mL cartridge (140 actuations)
VM - Veterinary Medicine
ENDOCRINE SYSTEM
Poison schedule: 4; Withholding period: N/A N/A; Host/pest details: HORSE - ADULT: [ASTHMA]
Registered
2023-07-01
Aservo EquiHaler 90307/128490 Product Name: APVMA Approval No: Label Name: Aservo EquiHaler Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY READ SAFETY DIRECTIONS Constituent Statements: 30 mg/mL (343 µg/actuation) ciclesonide Claims: For use by or under direction of a veterinarian. For the management of clinical signs associated with equine asthma in horses. Net Contents: 4.3 mL cartridge (140 actuations) Directions for Use: Use as directed by prescribing veterinarian. Restraints: DO NOT USE in horses that may be used for human consumption. Contraindications: This product is contraindicated for use in horses with known hypersensitivity to ciclesonide or corticosteroids. Precautions: The safety of this product has not been established in horses weighing less than 200 kg body weight, or in foals. The safety of this product has not been established in pregnant or lactating mares. Due to the potential for exacerbation of clinical signs of laminitis, glucocorticoids should be used with caution in horses with a history of laminitis, or horses otherwise at a higher risk for laminitis. Use with caution in horses with chronic nephritis, equine pituitary pars intermedia dysfunction (PPID), and congestive heart failure. RLP APPROVED Concurrent use of other anti-inflammatory drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs) or other corticosteroids, should be approached with caution. Due to the potential for systemic exposure, concomitant use of NSAIDs and corticosteroids may increase the risk of gastrointestinal, renal, and other toxicity. Side Effects: Mild nasal discharge. In case of overdose, symptomatic treatment should be initiated. Dosage and Administration: Use the contents within 12 days of first activating the cartridge. Discard unused portion (including the inhaler). For intranasal inhalation only. The number of actuations administered is the same for all horses independent of their bodyweight. The total treatment duration is 10 days: Days 1 to 5 8 اقرأ الوثيقة كاملة